Sdamlo 5 MG Powder for Oral Solution

RxCUI
2726067
RxNorm name
Sdamlo 5 MG Powder for Oral Solution
Display name
Sdamlo 5 MG Powder for Oral Solution
Full name
Sdamlo 5 MG Powder for Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SdamloAMLODIPINEPangea Pharmaceuticals, LLC886a7f97-60a4-4206-a6c7-5206069ed4872025-11-03Warnings, Adverse reactionsExact identifier
rxcui: 2726067

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
886a7f97-60a4-4206-a6c7-5206069ed487Sdamlo 5 MG Powder for Oral SolutionPSN4These highlights do not include all the information needed to use Sdamlo safely and effectively. See full prescribing information for Sdamlo. Sdamlo (amlodipine) for oral solution. Initial U.S. Approval: 199220251103
886a7f97-60a4-4206-a6c7-5206069ed487amlodipine 5 MG Powder for Oral Solution [Sdamlo]SBD4These highlights do not include all the information needed to use Sdamlo safely and effectively. See full prescribing information for Sdamlo. Sdamlo (amlodipine) for oral solution. Initial U.S. Approval: 199220251103
886a7f97-60a4-4206-a6c7-5206069ed487Sdamlo 5 MG Powder for Oral SolutionSY4These highlights do not include all the information needed to use Sdamlo safely and effectively. See full prescribing information for Sdamlo. Sdamlo (amlodipine) for oral solution. Initial U.S. Approval: 199220251103